"Item Id","Item URI","Dublin Core:Title","Dublin Core:Subject","Dublin Core:Description","Dublin Core:Creator","Dublin Core:Source","Dublin Core:Publisher","Dublin Core:Date","Dublin Core:Contributor","Dublin Core:Rights","Dublin Core:Relation","Dublin Core:Format","Dublin Core:Language","Dublin Core:Type","Dublin Core:Identifier","Dublin Core:Coverage","Item Type Metadata:Bibliography","Item Type Metadata:Biographical Text","Item Type Metadata:Occupation","Item Type Metadata:Death Date","Item Type Metadata:Birthplace","Item Type Metadata:Text","Item Type Metadata:Player","Item Type Metadata:Access","Item Type Metadata:Alternate URL","Item Type Metadata:Citation","Item Type Metadata:Accessibility","Item Type Metadata:Abstract","Item Type Metadata:Read Online","Item Type Metadata:Additional Exercise","Item Type Metadata:Email Body","Item Type Metadata:Interviewer","Item Type Metadata:Interviewee","Item Type Metadata:Location","Item Type Metadata:Transcription","Item Type Metadata:Local URL","Item Type Metadata:Original Format","Item Type Metadata:Physical Dimensions","Item Type Metadata:Duration","Item Type Metadata:Compression","Item Type Metadata:Producer","Item Type Metadata:Director","Item Type Metadata:Bit Rate/Frequency","Item Type Metadata:Time Summary","Item Type Metadata:Birth Date","Item Type Metadata:Subject Line","Item Type Metadata:From","Item Type Metadata:To","Item Type Metadata:CC","Item Type Metadata:BCC","Item Type Metadata:Number of Attachments","Item Type Metadata:Standards","Item Type Metadata:Objectives","Item Type Metadata:Materials","Item Type Metadata:Lesson Plan Text","Item Type Metadata:URL","Item Type Metadata:Event Type","Item Type Metadata:Participants","PDF Text:Text",tags,file,itemType,collection,public,featured
1810,https://repository.netecweb.org/items/show/1810,"NETEC: Annual Report FY2023",Research,"The Year 8 Annual Report for NETEC from 2023.",NETEC,,,2024-03-07,"No review - annual report.",,,,,Publication,,"No review - annual report.",,,,,,,,,,"Emory University, University of Nebraska Medical Center, Nebraska Medicine, NYC Health + Hospitals, Bellevue. 2023. NETEC Annual Report FY2022.","Free Online",,https://netec.org/2024/03/07/netec-annual-report-2023-advancing-special-pathogen-preparedness-and-collaboration/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/about-netec/annual-reports/,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/ae85d7a61643ab11aa4ac08f31294d33.pdf,Publication,Discover,1,0
1784,https://repository.netecweb.org/items/show/1784,"NETEC: Annual Report FY2022",Research,"The Year 7 Annual Report for NETEC from 2022.",NETEC,,,2023-08-07,"No review - annual report.",,,,,Publication,,"No review - annual report.",,,,,,,,,,"Emory University, University of Nebraska Medical Center, Nebraska Medicine, NYC Health + Hospitals, Bellevue. 2023. NETEC Annual Report FY2022.","Free Online",,https://netec.org/wp-content/uploads/2023/08/NETEC-FY2022-Annual-Report.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/wp-content/uploads/2023/08/NETEC-FY2022-Annual-Report.pdf,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/fc9b335ced2a3aaaffa5d07f0d838af7.pdf,Publication,Discover,1,0
1691,https://repository.netecweb.org/items/show/1691,"The Utility and Sustainability of US Ebola Treatment Centers during the COVID-19 Pandemic",Research,"In response to the 2014-2016 West Africa Ebola virus disease (EVD) epidemic, the Centers for Disease Control and Prevention (CDC) designated 56 US hospitals as Ebola treatment centers (ETCs) with high-level isolation capabilities. We aimed to determine ongoing sustainability of ETCs and identify how ETC capabilities have impacted hospital, local, and regional COVID-19 readiness and response.","Jocelyn J Herstein, Paul D Biddinger, Shawn G Gibbs, Angela L Hewlett, Aurora B Le, Michelle M Schwedhelm, John J Lowe",,,2022-02-22,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,Publication,,2024-07-25,,,,,,,,,,"Herstein, J. J., P. D. Biddinger, S. G. Gibbs, A. L. Hewlett, A. B. Le, M. M. Schwedhelm, and J. J. Lowe. 2022. ""The Utility and Sustainability of US Ebola Treatment Centers during the COVID-19 Pandemic."" Infect Control Hosp Epidemiol:1-33. doi: 10.1017/ice.2022.43.","Online through Cambridge core subscription.","Objective:
In response to the 2014-2016 West Africa Ebola virus disease (EVD) epidemic, the Centers for Disease Control and Prevention (CDC) designated 56 US hospitals as Ebola treatment centers (ETCs) with high-level isolation capabilities. We aimed to determine ongoing sustainability of ETCs and identify how ETC capabilities have impacted hospital, local, and regional COVID-19 readiness and response.
Design:
An electronic survey included both qualitative and quantitative questions and was structured into two sections: operational sustainability and role in the COVID-19 response.
Setting and Participants:
The survey was distributed to site representatives from the 56 originally designated ETCs; 37 (66%) responded.
Methods:
Data were coded and analyzed using descriptive statistics.
Results:
Of the 37 responding ETCs, 33 (89%) reported they were still operating while 4 had decommissioned. ETCs that maintain high-level isolation capabilities incurred a mean of $234,367 in expenses per year. All but one ETC reported that existing capabilities (e.g., trained staff, infrastructure) before COVID-19 positively affected their hospital, local, and regional COVID-19 readiness and response (e.g., ETCs trained staff, donated supplies, and shared developed protocols).
Conclusions:
Existing high-level isolation capabilities and expertise developed following the 2014-2016 EVD epidemic were leveraged by ETCs to assist hospital-wide readiness for COVID-19 and support response for other local and regional hospitals However, ETCs face continued challenges in sustaining those capabilities for high-consequence infectious diseases.
",https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/abs/utility-and-sustainability-of-us-ebola-treatment-centers-during-the-covid19-pandemic/C7BAFF7DCF5EAD49D67C37FCE04835BC,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35189995/,,,,"2019-nCoV,COVID-19,Ebola,Isolation/Biocontainment,NETEC,Pandemic,R-Res&Pub,Research,Treatment and Care,Treatment Facility",,Publication,Discover,1,0
1641,https://repository.netecweb.org/items/show/1641,"NETEC: Annual Report FY2020",Research,"The Year 5 Annual Report for NETEC from 2020.",NETEC,,,2020-12,"No review - annual report.",,,,,,,"No review - annual report.",,,,,,,,,,"Emory University, University of Nebraska Medical Center, Nebraska Medicine, NYC Health + Hospitals, Bellevue. 2021. NETEC Annual Report FY2020.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/aa2d17bf1e4fdc12014e41e6edbd0704.pdf,Publication,Discover,1,0
1640,https://repository.netecweb.org/items/show/1640,"NETEC: Annual Report FY2019",Research,"The Year 4 Annual Report for NETEC from 2019.",NETEC,,,2020-07,"No review - annual report.",,,,,,,"No review - annual report.",,,,,,,,,,"Emory University, University of Nebraska Medical Center, Nebraska Medicine, NYC Health + Hospitals, Bellevue. 2020. NETEC Annual Report FY2019.",,,https://netec.org/about/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/f8d6a7145abd36d7c530d7d2bbab2124.pdf,Publication,Discover,1,0
1639,https://repository.netecweb.org/items/show/1639,"NETEC: Annual Report FY2021",Research,"The Year 6 Annual Report for NETEC from 2021.",NETEC,,,2021-10-26,"No review - annual report.",,,,,,,"No review - annual report.",,,,,,,,,,"Emory University, University of Nebraska Medical Center, Nebraska Medicine, NYC Health + Hospitals, Bellevue. 2021. NETEC Annual Report FY2021.","Free online","
",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://indd.adobe.com/view/5544d560-f343-493f-a267-2e8a799a7626,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/788e056b1f9c24c0f4738fc61e30992c.pdf,Publication,Discover,1,0
408,https://repository.netecweb.org/items/show/408,"NETEC: Annual Report FY2018",Research,"The Year 3 Annual Report for NETEC from 2018.",NETEC,,,2018-02-06,"No review - annual report.",,,,,,,"No review - annual report.",,,,,,,,,,"Emory University, University of Nebraska Medical Center, Nebraska Medicine, NYC Health + Hospitals, Bellevue. 2019. NETEC Annual Report FY2018.",,,https://netec.org/about/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/02f551472896d6e64bf1aa372aece445.pdf,Publication,Discover,1,0
407,https://repository.netecweb.org/items/show/407,"NETEC: Annual Report FY2017",Research,"The Year 2 Annual Report for NETEC from 2017. ",NETEC,,,2018-01-04,"No review - annual report.",,,,,,,"No review - annual report.",,,,,,,,,,"Emory University, University of Nebraska Medical Center, Nebraska Medicine, NYC Health + Hospitals, Bellevue. 2018. NETEC Annual Report FY2017.",,,https://netec.org/2018/01/04/read-the-2017-netec-annual-report/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/5734f16ba00bf341aa05cf90f6d25384.pdf,Publication,Discover,1,0
406,https://repository.netecweb.org/items/show/406,"NETEC: Annual Report FY2016",Research,"The Year 1 Annual Report for NETEC from 2016.",NETEC,,,2017-01,"No review - annual report.",,,,,,,"No review - annual report.",,,,,,,,,,"Cagliuso, N., S. Madad, C. Kraft, J. Lowe, S. Anderson-Fiore, J. Hillman, and W. ElRayes. 2017. NETEC Annual Report FY2016.",,,https://netec.org/about/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NETEC,R-Lead",https://repository.netecweb.org/files/original/cd71c412de0da4192304d22a1fd38261.pdf,Publication,Discover,1,0
1785,https://repository.netecweb.org/items/show/1785,"Travel-Related Infectious Diseases: A Guide for Health Care Professionals","Infection Control","The dog days of summer are upon us, and many people are taking advantage of the final weeks before cooler temperatures arrive to embark on vacations. While travel offers exciting adventures, it also carries the potential for illness. From minor issues like traveler’s diarrhea to serious high-consequence infectious diseases, health care professionals must be prepared to address travel-related health concerns and provide guidance to patients on how to prevent illness. Here are some essential reminders for patient care:
",NETEC,,,2023-08-03,,,,,,,,2024-08-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/2023/08/08/travel-related-infectious-diseases-a-guide-for-health-care-professionals/,,,,"Blog,Malaria,Mosquito,NETEC,R-IPC,Tick",https://repository.netecweb.org/files/original/6274083c1510b7d63b23d191d8c0b254.png,Hyperlink,Discover,1,0
150,https://repository.netecweb.org/items/show/150,"The National Ebola Training and Education Center: Preparing the United States for Ebola and Other Special Pathogens",General,"The National Ebola Training and Education Center (NETEC) was established in 2015 in response to the 2014-2016 Ebola virus disease outbreak in West Africa. ","Kratochvil, C. J., L. Evans, B. S. Ribner, J. J. Lowe, M. C. Harvey, R. C. Hunt, A. J. Tumpey, R. P. Fagan, M. M. Schwedhelm, S. Bell, J. Maher, C. S. Kraft, N. V. Cagliuso, Sr., S. Vanairsdale, A. Vasa and P. W. Smith",,,2017-06-01,"2022-01-10 by PPE group Shawn Gibbs",,,,,Publication,,2025-01-10,,,,,,,,,,"Kratochvil, C. J., L. Evans, B. S. Ribner, J. J. Lowe, M. C. Harvey, R. C. Hunt, A. J. Tumpey, R. P. Fagan, M. M. Schwedhelm, S. Bell, J. Maher, C. S. Kraft, N. V. Cagliuso, Sr., S. Vanairsdale, A. Vasa and P. W. Smith (2017). ""The National Ebola Training and Education Center: Preparing the United States for Ebola and Other Special Pathogens."" Health Secur 15(3): 253-260.","pay online - or through Liebert connect, author manuscript free on PubMed Central","The National Ebola Training and Education Center (NETEC) was established in 2015 in response to the 2014-2016 Ebola virus disease outbreak in West Africa. The US Department of Health and Human Services office of the Assistant Secretary for Preparedness and Response and the US Centers for Disease Control and Prevention sought to increase the competency of healthcare and public health workers, as well as the capability of healthcare facilities in the United States, to deliver safe, efficient, and effective care to patients infected with Ebola and other special pathogens nationwide. NYC Health + Hospitals/Bellevue, Emory University, and the University of Nebraska Medical Center/Nebraska Medicine were awarded this cooperative agreement, based in part on their experience in safely and successfully evaluating and treating patients with Ebola virus disease in the United States. In 2016, NETEC received a supplemental award to expand on 3 initial primary tasks: (1) develop metrics and conduct peer review assessments; (2) develop and provide educational materials, resources, and tools, including exercise design templates; (3) provide expert training and technical assistance; and, to add a fourth task, create a special pathogens clinical research network.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532632/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/28636442,,,,"Ebola,Isolation/Biocontainment,NETEC,Personal Protective Equipment (PPE),R-PPE,Special Pathogens,Training",,Publication,Discover,1,0
1685,https://repository.netecweb.org/items/show/1685,"COVID-19 Response Among US Hospitals with Emerging Special Pathogen Programs","Emergency Response","In February 2015, the US Department of Health and Human Services developed a tiered hospital network to deliver safe and effective care to patients with Ebola virus disease (EVD) and other special pathogens. The tiered network consisted of regional special pathogen treatment centers, state- or jurisdiction-designated treatment centers, assessment hospitals able to safely isolate a patient until a diagnosis of EVD was confirmed and transfer the patient, and frontline healthcare facilities able to identify and isolate patients with EVD and facilitate transport to higher-tier facilities. The National Emerging Special Pathogens Training and Education Center (NETEC) was established in tandem to support the development of healthcare facility special pathogen management capabilities.","Angela Vasa, Valerie Pacino, Sami Vasistha, Wael ElRayes, John J Lowe",,,2022-05-31,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,Publication,,2024-07-20,,,,,,,,,,"Vasa, A., V. Pacino, S. Vasistha, W. ElRayes, and J. J. Lowe. 2022. ""COVID-19 Response Among US Hospitals with Emerging Special Pathogen Programs."" Health Secur 20 (S1):S31-s38. doi: 10.1089/hs.2021.0193.","Open Access on journal site","In February 2015, the US Department of Health and Human Services developed a tiered hospital network to deliver safe and effective care to patients with Ebola virus disease (EVD) and other special pathogens. The tiered network consisted of regional special pathogen treatment centers, state- or jurisdiction-designated treatment centers, assessment hospitals able to safely isolate a patient until a diagnosis of EVD was confirmed and transfer the patient, and frontline healthcare facilities able to identify and isolate patients with EVD and facilitate transport to higher-tier facilities. The National Emerging Special Pathogens Training and Education Center (NETEC) was established in tandem to support the development of healthcare facility special pathogen management capabilities. In August 2020, 20 hospitals that previously received an onsite readiness consultation by NETEC were surveyed to assess how special pathogen programs were leveraged for COVID-19 response. All surveyed facilities indicated their programs were leveraged for COVID-19 response in at least 1 of the following ways: NETEC-sponsored resources and training, utilization of patient isolation spaces, specially trained staff, and supplies. Personal protective equipment shortages were experienced by 95% of facilities, with 80% of facilities reporting that special pathogens program personal protective equipment was used to support facility response to COVID-19 admissions. More than half of facilities (63%) reported leveraging biocontainment unit staff to provide training and education to frontline staff during initial response to COVID-19. These findings have implications for planning and investments to avoid the panic-then-forget cycle that hinders sustained preparedness for future special pathogens.",https://www.liebertpub.com/doi/10.1089/hs.2021.0193,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35584272/,,,,"Ebola,Emergency Management,Isolation/Biocontainment,NETEC,Outbreaks,R-Res&Pub,Research,Special Pathogens,Viral Hemorrhagic Fever",,Publication,Discover,1,0
1683,https://repository.netecweb.org/items/show/1683,"Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial","Emergency Management","The need for well-controlled clinical trials is fundamental to advancing medicine. Care should be taken to maintain high standards in trial design and conduct even during emergency medical events such as an infectious disease outbreak. In 2020, SARS-CoV-2 emerged and rapidly impacted populations around the globe.","Corri B Levine, Sami Vasistha, Caroline Croyle Persson, LuAnn R Larson, Christopher J Kratochvil, Aneesh K Mehta, Lindsay J Hicks, Abigail E Lowe, Mark G Kortepeter, Lauren M Sauer",,,2022-05-31,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,Publication,,2024-07-20,,,,,,,,,,"Levine, C. B., S. Vasistha, C. C. Persson, L. R. Larson, C. J. Kratochvil, A. K. Mehta, L. J. Hicks, A. E. Lowe, M. G. Kortepeter, and L. M. Sauer. 2022. ""Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial."" Health Secur 20 (S1):S20-s30. doi: 10.1089/hs.2021.0178.
","Open Access on journal site","The need for well-controlled clinical trials is fundamental to advancing medicine. Care should be taken to maintain high standards in trial design and conduct even during emergency medical events such as an infectious disease outbreak. In 2020, SARS-CoV-2 emerged and rapidly impacted populations around the globe. The need for effective therapeutics was immediately evident, prompting the National Institutes of Health to initiate the Adaptive COVID-19 Treatment Trial. The Special Pathogens Research Network, made up of 10 Regional Emerging Special Pathogens Treatment Centers, was approached to participate in this trial and readily joined the trial on short notice. By trial closure, the Special Pathogens Research Network sites, making up 19% of all study sites, enrolled 26% of the total participants. The initial resources available and experience in running clinical trials at each treatment center varied from minimal experience and few staff to extensive experience and a large staff. Based on experiences during the first phase of this trial, the Special Pathogens Research Network members provided feedback regarding operational lessons learned and recommendations for conducting future studies during a pandemic. Communication, collaboration, information technology, regulatory processes, and access to resources were identified as important topics to address. Key stakeholders including institutions, institutional review boards, and study personnel must maintain routine communication to efficiently and effectively activate when future research needs arise. Regular and standardized training for new personnel will aid in transitions and project continuity, especially in a rapidly evolving environment. Trainings should include local just-in-time training for new staff and sponsor-designed modules to refresh current staff knowledge. We offer recommendations that can be used by institutions and sponsors to determine goals and needs when preparing to set up this type of trial for critical, short-notice needs.",https://www.liebertpub.com/doi/10.1089/hs.2021.0178,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35483093/,,,,"Clinical Trial,Emergency Management,NETEC,Pandemic,R-Res&Pub,Research,Special Pathogens,Trial",,Publication,Discover,1,0
1682,https://repository.netecweb.org/items/show/1682,"The Evolution of the National Special Pathogen System of Care","Emergency Management","Infectious disease outbreaks and pandemics have repeatedly threatened public health and have severely strained healthcare delivery systems throughout the past century. Pathogens causing respiratory illness, such as influenza viruses and coronaviruses, as well as the highly communicable viral hemorrhagic fevers, pose a large threat to the healthcare delivery system in the United States and worldwide. ","Vikramjit Mukherjee, Lauren M Sauer, Aneesh K Mehta, Sophia Y Shea, Paul D Biddinger, Brendan G Carr, Laura E Evans, Shelly Schwedhelm, John J Lowe, John J Lowe",,,2022-05-31,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,Publication,,2024-07-20,,,,,,,,,,"Mukherjee, V., L. M. Sauer, A. K. Mehta, S. Y. Shea, P. D. Biddinger, B. G. Carr, L. E. Evans, S. Schwedhelm, J. J. Lowe, and J. J. Lowe. 2022. ""The Evolution of the National Special Pathogen System of Care."" Health Secur 20 (S1):S39-s48. doi: 10.1089/hs.2022.0026.
","Open Access on journal site","Infectious disease outbreaks and pandemics have repeatedly threatened public health and have severely strained healthcare delivery systems throughout the past century. Pathogens causing respiratory illness, such as influenza viruses and coronaviruses, as well as the highly communicable viral hemorrhagic fevers, pose a large threat to the healthcare delivery system in the United States and worldwide. Through the Hospital Preparedness Program, within the US Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, a nationwide Regional Ebola Treatment Network (RETN) was developed, building upon a state- and jurisdiction-based tiered hospital approach. This network, spearheaded by the National Emerging Special Pathogens Training and Education Center, developed a conceptual framework and plan for the evolution of the RETN into the National Special Pathogen System of Care (NSPS). Building the NSPS strategy involved reviewing the literature and the initial framework used in forming the RETN and conducting an extensive stakeholder engagement process to identify gaps and develop solutions. From this, the NSPS strategy and implementation plan were formed. The resulting NSPS strategy is an ambitious but critical effort that will have impacts on the mitigation efforts of special pathogen threats for years to come.",https://www.liebertpub.com/doi/10.1089/hs.2022.0026,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35587214/,,,,"Communications,Emergency Management,NETEC,Outbreaks,Pandemic,R-Res&Pub,Research,Special Pathogens",,Publication,Discover,1,0
1681,https://repository.netecweb.org/items/show/1681,"Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response","Emergency Management","The National Emerging Special Pathogens Training and Education Center (NETEC) was established in 2015 to improve the capabilities of healthcare facilities to provide safe and effective care to patients with Ebola and other special pathogens in the United States.","Jonathan D Grein, Jennifer A Garland, Christa Arguinchona, Maria G Frank, Brian T Garibaldi, Amanda Grindle, Angela Hewlett, Susan Kline, Corri B Levine, Aneesh Mehta, Vikramjit Mukherjee, Lauren M Sauer, Eileen F Searle, Sharon Vanairsdale, Angela Vasa
",,,2022-05-31,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,Publication,,2024-07-20,,,,,,,,,,"Grein, J. D., J. A. Garland, C. Arguinchona, M. G. Frank, B. T. Garibaldi, A. Grindle, A. Hewlett, S. Kline, C. B. Levine, A. Mehta, V. Mukherjee, L. M. Sauer, E. F. Searle, S. Vanairsdale, and A. Vasa. 2022. ""Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response."" Health Secur 20 (S1):S4-s12. doi: 10.1089/hs.2021.0188.
","Open Access on journal site","The National Emerging Special Pathogens Training and Education Center (NETEC) was established in 2015 to improve the capabilities of healthcare facilities to provide safe and effective care to patients with Ebola and other special pathogens in the United States. Through NETEC, a collaborative network of 10 Regional Emerging Special Pathogen Treatment Centers (RESPTCs) undertook readiness activities that included potential respiratory pathogens. These preparations, which took place before the COVID-19 pandemic, established a foundation of readiness that enabled RESPTCs to play a pivotal role in the US COVID-19 pandemic response. As initial COVID-19 cases were detected in the United States, RESPTCs provided essential isolation capacity, supplies, and subject matter expertise that allowed for additional time for healthcare systems to prepare. Through the Special Pathogen Research Network, RESPTCs rapidly enrolled patients into early clinical trials. During periods of high community transmission, RESPTCs provided educational, clinical, and logistical support to a wide range of healthcare and nonhealthcare settings. In this article, we describe how NETEC and the RESPTC network leveraged this foundation of special pathogen readiness to strengthen the national healthcare system's response to the COVID-19 pandemic. NETEC and the RESPTC network have proven to be an effective model that can support the national response to future emerging special pathogens.",https://www.liebertpub.com/doi/10.1089/hs.2021.0188,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35483049/,,,,"Emergency Management,NETEC,Pandemic,R-Res&Pub,Research,Special Pathogens,Treatment Facility",,Publication,Discover,1,0